Composting may serve as a practical and economical means of disposing of specified risk materials (SRM) or animal mortalities potentially infected with prion diseases (transmissible spongiform encephalopathies, TSE). Our study investigated the degradation of prions associated with scrapie (PrP(263K)), chronic waste disease (PrP(CWD)), and bovine spongiform encephalopathy (PrP(BSE)) in lab-scale composters and PrP(263K) in field-scale compost piles. Western blotting (WB) indicated that PrP(263K), PrP(CWD), and PrP(BSE) were reduced by at least 2 log10, 1-2 log10, and 1 log10 after 28 days of lab-scale composting, respectively. Further analysis using protein misfolding cyclic amplification (PMCA) confirmed a reduction of 2 log10 in PrP(263K) and 3 log10 in PrP(CWD). Enrichment for proteolytic microorganisms through the addition of feather keratin to compost enhanced degradation of PrP(263K) and PrP(CWD). For field-scale composting, stainless steel beads coated with PrP(263K) were exposed to compost conditions and removed periodically for bioassays in Syrian hamsters. After 230 days of composting, only one in five hamsters succumbed to TSE disease, suggesting at least a 4.8 log10 reduction in PrP(263K) infectivity. Our findings show that composting reduces PrP(TSE), resulting in one 50% infectious dose (ID50) remaining in every 5600 kg of final compost for land application. With these considerations, composting may be a viable method for SRM disposal.

Misfolded prions (PrP Sc ) are well known for their resistance to conventional decontamination processes. The potential risk of contamination of the water environment, as a result of disposal of specified risk materials (SRM), has raised public concerns. Ozone is commonly utilized in the water industry for inactivation of microbial contaminants and was tested in this study for its ability to inactivate prions (263K hamster scrapie ‫؍‬ PrP Sc ). Treatment variables included initial ozone dose (7.6 to 25.7 mg/liter), contact time (

eThe kinetics of ozone inactivation of infectious prion protein (PrP Sc , scrapie 263K) was investigated in ozone-demand-free phosphate-buffered saline (PBS). Diluted infectious brain homogenates (IBH) (0.01%) were exposed to a predetermined ozone dose (10.8 ؎ 2.0 mg/liter) at three pHs (pH 4.4, 6.0, and 8.0) and two temperatures (4°C and 20°C). The inactivation of PrP Sc was quantified by determining the in vitro destruction of PrP Sc templating properties using the protein misfolding cyclic amplification (PMCA) assay and bioassay, which were shown to correlate well. The inactivation kinetics were characterized by both Chick-Watson (CW) and efficiency factor Hom (EFH) models. It was found that the EFH model fit the experimental data more appropriately. The efficacy of ozone inactivation of PrP Sc was both pH and temperature dependent. Based on the EFH model, CT (disinfectant concentration multiplied by contact time) values were determined for 2-log 10 , 3-log 10 , and 4-log 10 inactivation at the conditions under which they were achieved. Our results indicated that ozone is effective for prion inactivation in ozone-demand-free water and may be applied for the inactivation of infectious prion in prion-contaminated water and wastewater.

No abstract

Protein crystallization generally consists of an initial screen followed by optimization of promising conditions. Whereas the initial screen typically uses a standard set of pre-made crystallization cocktails, optimization requires new cocktails with small perturbations of the original composition. Highly parallel synchronous crystallization robots are ideal for initial screening, but they depend on pre-made crystallization cocktails. Asynchronous crystallization robots can create crystallization cocktails from stock solutions, but in practice this ability is rarely exploited. Instead, large-scale operations typically use a general liquid-handling robot to create optimization screens, whereas academics mostly rely on manual optimization. Here, the use of an asynchronous crystallization robot to create customized crystallization cocktails and set up nanovolume crystallization experiments without a compromise in speed or drop quality is described. This approach avoids the complex integration of hardware, software and dataflow between two robots and saves cost and space. As a proof of principle, a commercial crystal screen has been reproduced with the robot and shows that results are virtually identical to using the actual commercial screen.